The APTIMA HPV assay versus the Hybrid Capture 2 test in triage of women with ASC-US or LSIL cervical cytology: a meta-analysis of the diagnostic accuracy.
about
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesionsCervical cancer screening: A never-ending developing programE6/E7 mRNA testing for human papilloma virus-induced high-grade cervical intraepithelial disease (CIN2/CIN3): a promising perspectiveImmediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test.Diagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.Immediate referral to colposcopy versus cytological surveillance for low-grade cervical cytological abnormalities in the absence of HPV test: A systematic review and a meta-analysis of the literature.ANOVA model for network meta-analysis of diagnostic test accuracy data.Assessment of high-risk human papillomavirus infections using clinician- and self-collected cervical sampling methods in rural women from far western Nepal.HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 human papillomavirus genotype microarray system.Comparative evaluation of three commercial systems for detection of high-risk human papillomavirus in cervical and vaginal ThinPrep PreservCyt samples and correlation with biopsy resultsThe clinical performance of APTIMA human papillomavirus and Hybrid Capture 2 assays in the triage of lesser abnormal cervical cytologiesPrognostic value of HPV E6/E7 mRNA assay in women with negative colposcopy or CIN1 histology result: a follow-up study.Assessing the detection of human papillomavirus late mRNA in liquid base cytology samples for risk stratification of cervical disease.A study of genotyping for management of human papillomavirus-positive, cytology-negative cervical screening resultsTriage of HR-HPV positive women with minor cytological abnormalities: a comparison of mRNA testing, HPV DNA testing, and repeat cytology using a 4-year follow-up of a population-based study.Comparison of HPV genotyping and methylated ZNF582 as triage for women with equivocal liquid-based cytology results.5-type HPV mRNA versus 14-type HPV DNA test: test performance, over-diagnosis and overtreatment in triage of women with minor cervical lesions.Predictive value of p16/Ki-67 immunocytochemistry for triage of women with abnormal Papanicolaou test in cervical cancer screening: a systematic review and meta-analysis.EUROGIN 2011 roadmap on prevention and treatment of HPV-related diseaseTriage of HPV positive women in cervical cancer screening.Five-year risks of CIN 2+ and CIN 3+ among women with HPV-positive and HPV-negative LSIL Pap results.Production of functional, stable, unmutated recombinant human papillomavirus E6 oncoprotein: implications for HPV-tumor diagnosis and therapy.The Aptima HPV assay fulfills the cross-sectional clinical and reproducibility criteria of international guidelines for human papillomavirus test requirements for cervical screeningDisagreement between human papillomavirus assays: an unexpected challenge for the choice of an assay in primary cervical screening.Comparison of commercial hybridization and automated transcription-mediated amplification modalities for detection of high-risk human papillomavirus nucleic acid.Triage of women with minor abnormal cervical cytology: meta-analysis of the accuracy of an assay targeting messenger ribonucleic acid of 5 high-risk human papillomavirus types.Understanding HPV tests and their appropriate applications.The current position and the future perspectives of cervical cancer screening.DNA methylation and detection of cervical cancer and precancerous lesions using molecular methods.Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.Performance of mRNA- and DNA-based high-risk human papillomavirus assays in detection of high-grade cervical lesions.Using novel biomarkers to triage young adult women with minor cervical lesions: a cost-effectiveness analysis.Hybrid Capture 2 and cobas human papillomavirus assays perform similarly on SurePath samples from women with abnormalities.Follow up with HPV test and cytology as test of cure, 6 months after conization, is reliable.Human papillomavirus mRNA and DNA testing in women with atypical squamous cells of undetermined significance: A prospective cohort study.Use of HPV testing for cervical screening in vaccinated women--Insights from the SHEVa (Scottish HPV Prevalence in Vaccinated Women) study.Sensitivity of APTIMA HPV E6/E7 mRNA test in comparison with hybrid capture 2 HPV DNA test for detection of high risk oncogenic human papillomavirus in 396 biopsy confirmed cervical cancers.High performance of combined HPV testing and genotyping for HPV16/18/52/58 in triaging women with minor cervical cytological abnormalities in northern Thailand.Human Papillomavirus Test for Triage of Japanese Women With Low-Grade Squamous Intraepithelial Lesions.High risk HPV testing in the triage of repeat ASC-US and LSIL.
P2860
Q24198236-F6EF601D-70E2-487A-AD5E-EEA2CFF703A1Q26798416-74C17F50-4DB7-4194-8F72-348CD94EB196Q28087374-32533A28-000D-4B9E-BD6C-2FD181F17FF2Q30238772-86AEFA18-28E0-46ED-A55E-6C9B53C9D369Q30241076-5F3C8550-029A-434A-893E-0EDA50807ED6Q30245568-C0EE16CB-68DA-4798-9BCD-4B8BCCF471AEQ31132331-EEAF73D2-6536-4D4B-A4AE-723360B52B5FQ33825915-A66A6273-62D4-4716-91D6-B159BD806642Q34006684-42B85F32-5C24-4751-AC16-44899AB92404Q34298145-13C80545-DB72-4197-9DAD-A120354A7C1BQ34330297-5B1AD809-48FC-4182-889A-260C1DEDBD60Q34608714-5A024BE9-15A7-4065-9676-B5186983A5A1Q34806026-D1635DBE-9A88-4B90-A234-542F5AB59F9FQ34916671-DAE1E3B2-A63A-4400-A26B-3AD720AC7BF2Q35108590-FD5EBE33-E721-48B5-940D-C58FB78E20AFQ35568812-181A6195-AE17-4D1F-BE93-FB8036E1DC55Q36046119-480EB125-04B8-4C1E-AE3A-256905415B89Q36091529-239FDACC-954E-48B4-AE2B-FBE04F8F4D82Q36194955-E4D91B69-6851-4F53-B2D5-6776278762CDQ36679896-42AD120F-E9A3-4F04-924E-0AA07B006463Q36799898-02DCD4C8-7E32-472D-8D1B-1A6B12C24DE9Q37133152-B95F96FF-3D7B-46F5-926A-13608A68D8EFQ37470374-649841F0-A516-47EE-BD0E-7FC1E748C0EFQ37496183-90E8345C-A7FA-4295-81DF-6FBB1B53A2CAQ37546570-89D34D2C-6F40-4F9D-A236-817A1DB13BDEQ38123772-B967B43B-87F1-439F-AA30-16E54D2E8C1FQ38133612-8826517C-C572-4C23-BBDF-CC80A07C0AC2Q38168923-0B073C01-6BBB-49C6-AA6A-DFBD0A9AF85AQ38605348-A4EEFDAD-C806-40B7-86EB-BC0560F00D58Q38752133-2EC6AAF8-B4B9-4E7E-8D76-9C08C5FBDB77Q39177983-607A3B97-287C-4947-A1FF-9DD814BD8024Q39708564-23122C0C-4384-44C3-833F-04DD4B9813FFQ39909954-72ED0092-878A-495D-8D94-4F0C504703F3Q40500436-0D2AB292-CA83-4DBC-B2B6-56F3C4E9C4BCQ40744991-52979D10-FE4D-4FEE-A542-10D624F638AEQ40805660-8F6F8C4C-7ED4-4193-BB42-C69A77F35B41Q40861259-77A0F276-A9F7-46DF-B1C0-E61BEC2A940DQ41130336-5FC46E9F-324A-4DEF-A860-0C7FE85B83BDQ41149856-C41943DC-31CC-4017-B0CB-70A06DE63D43Q41176779-0938650A-468D-46DB-B609-9ADCEC26F519
P2860
The APTIMA HPV assay versus the Hybrid Capture 2 test in triage of women with ASC-US or LSIL cervical cytology: a meta-analysis of the diagnostic accuracy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The APTIMA HPV assay versus th ...... is of the diagnostic accuracy.
@en
type
label
The APTIMA HPV assay versus th ...... is of the diagnostic accuracy.
@en
prefLabel
The APTIMA HPV assay versus th ...... is of the diagnostic accuracy.
@en
P2093
P2860
P356
P1476
The APTIMA HPV assay versus th ...... is of the diagnostic accuracy.
@en
P2093
Ann Szarewski
Jack Cuzick
Jerome L Belinson
Jolien Roelens
Joseph Monsonego
Kate Cuschieri
Marc Arbyn
Miriam Reuschenbach
Sam Ratnam
Suzanne Belinson
P2860
P304
P356
10.1002/IJC.27636
P577
2012-06-13T00:00:00Z